Skip to main content
Consumer site
KenvuePro Logo

Vaping in Great Britain

There are currently 4.7 million vapers in Great Britain, up 9% from 2022, with most vapers being ex-smokers (56%)1.The ultimate goal for some vapers is to stop using all nicotine products. In a UK survey, 31% of vapers wanted to quit vaping completely**2
**Survey of 1,510 UK vapers

Nicorette® QuickMist Mouthspray is clinically proven to relieve cravings to smoke or vape

NICE Guidelines recommend discussing how to stop with a vaper when they are ready to do so5.

Nicorette® QuickMist Mouthspray can relieve and prevent cravings and nicotine withdrawal symptoms associated with stopping vaping, making it a useful aid to support those on the path to quit nicotine completely6.

Also available as Nicorette QuickMist SmartTrack Mouthspray – The first stop vaping NRT spray that uses near field communication to connect to a vaping cessation behavioural support app

Learn more about Nicorette® QuickMist Mouthspray Vaping Indication

Vaping Cessation Factsheet

DownloadArrowRight

Vaping Cessation for Those Ready to Quit & Supporting Smokers Through Their Quitting Journey

Click here to watch webinarArrowRight

Nicorette QuickMist Product Leaflet

DownloadArrowRight

Nicorette QuickMist Indication Study Leaflet

DownloadArrowRight

Supporting vapers on their quit journey

Vaping nicotine, like smoking, can lead to nicotine dependence and cyclic withdrawal effects which can make quitting difficult7,9.

Nicorette® QuickMist can be used to relieve withdrawal symptoms and reduce vaping cravings when nicotine vapers try to quit4.

Gradually reduce the amount of Nicorette® QuickMist used each day until stopping use completely.

Your experience in smoking cessation is invaluable to vapers looking to quit, due to many similarities across the two habits. However, also be aware of important differences between vapers and smokers that may impact the cessation support they need.

Click here to learn moreArrowRight

It’s important to discuss with vapers how to stop when they are ready to move on.

Here are 4 steps you can follow to suport vapers on their quit journey.

Download hereArrowRight

Downloadable materials

Nicorette® QuickMist product leaflet

DownloadArrowRight

Nicorette® QuickMist Vaping Indication study leaflet

DownloadArrowRight

Vaping cessation factsheet

DownloadArrowRight

Advising vapers who want are ready to quit

DownloadArrowRight

Similarities and differences between vapers and smokers who want to quit

DownloadArrowRight
Download AllArrowRight

FAQs

The dosing schedule is as follows:

  • “Use 1 or 2 sprays when you would normally have smoked or vaped or if cravings emerge. If after the first spray cravings are not controlled within a few minutes, a second spray should be used. If 2 sprays are required, future doses may be delivered as 2 consecutive sprays.

  • You may use up to 4 sprays per hour. Do not exceed 2 sprays per dosing episode and 64 sprays (4 sprays per hour over 16 hours) in any 24-hour period.”

Nicorette® QuickMist Mouthspray is licenced for use as an aid for nicotine vaping cessation in those ready to quit vaping, this is in addition to the indication for smoking cessation.

Nicorette® QuickMist is also available for smoking cessation5

Nicorette® QuickMist is 2.5 times more effective at helping smokers quit compared with placebo at 52 weeks10.

  • Risk Ratio: 2.48

  • 95% CI: 1.24–4.94

Nicorette® QuickMist can support both smokers or vapers who want to quit and delivers fast craving relief11.

References

1. Action on Smoking and Health (ASH). Use of e-cigarettes (vapes) among adults in Great Britain. August 2023. Available here. (Accessed February 2024).2. Data on file; vapers' behaviour and attitudes, 2022.3. Electronic Medicines Compendium (EMC). Search results for nicotine. Available here. (Accessed November 2022).4. Nicorette® QuickMist 1mg/spray mouthspray SmPC.5. National Institute for Health and Care Excellence (NICE). Tobacco: preventing uptake, promoting quitting and treating dependence (NG209). Available here. (Accessed November 2022).6. Data on file; QuickMist vaping study, 2022.7. Hughes JR et al. Nicotine Tob Res 2020; 22:734–739.8. Simpson KA et al. Public Health 2021; 21:959.9. Prochaska JJ and Benowitz NL. Sci Adv 2019; 5:10.10. Tønnesen P et al. Eur Respir J 2012; 40:548–554.11. Hansson A et al. BMJ Open 2012; 2:e001618.

Click here for product information

UK-NIC-2025-185504
Date of preparation: June 2025